Stryker Mako Company Profile: History, Mako, Acquisitions, Financials and Stock
Updated: 7 days ago
Stryker is an American medical technology company that owns Mako, a robotic arm system used in joint replacement surgery. Homer Stryker founded it in 1941; it reported revenue of USD 25.12 billion for 2025. This profile sets out its history, the Mako business, acquisitions, figures and listing.
Stryker at a Glance
Fact | Detail |
Company | Stryker Corporation |
Founded | 1941, as The Orthopedic Frame Company |
Founder | Homer Stryker |
Headquarters | Portage, Michigan, USA |
Employees | 53,000 in 2024 |
Revenue | USD 25.12 billion, 2025 |
Net income | USD 3.25 billion, 2025 |
Stock listing | NYSE: SYK |
Chairman and CEO | Kevin A. Lobo, CEO since October 2012 |
Company History
Homer Stryker, an orthopedist, founded The Orthopedic Frame Company in 1941. It was renamed Stryker Corporation in 1964 and has grown largely through acquisitions.
Mako
Stryker acquired Mako Surgical in December 2013 for USD 1.65 billion. Mako's products are platforms in which a robotic arm assists the surgeon, the best known being the RIO, the Robotic Arm Interactive Orthopedic System. The purchase also brought implants used in partial knee and total hip replacement.
Major Acquisitions
1998: Howmedica, the orthopaedic division of Pfizer, for USD 1.9 billion.
2011: Neurovascular division of Boston Scientific, USD 1.5 billion.
2013: Mako Surgical, USD 1.65 billion.
2016: Sage Products, USD 2.78 billion, and Physio-Control, USD 1.28 billion.
2020: Wright Medical Group, USD 5.4 billion.
2022: Vocera Communications, USD 2.97 billion.
2025: Inari Medical, USD 4.9 billion.
Financial Performance
Item | 2025 |
Revenue | USD 25.12 billion |
Net income | USD 3.25 billion |
Net margin | About 13% |
Stock Information
Stryker trades on the New York Stock Exchange under the ticker SYK.
Note: this section is general information, not investment advice.
Leadership
Name | Role |
Kevin A. Lobo | Chairman and Chief Executive Officer |
Strengths and Challenges
Strengths
A leading robot in orthopedic surgery tied to the company's own implants.
Scale and steady profitability.
Long-serving leadership.
Challenges
Competing orthopedic robots from other implant makers.
Integration of frequent large acquisitions.
Current Catalogue Coverage
Catalogue checked on 15 October 2026: 1 associated product records. The links below are representative entries, rather than a claim that every historical model is currently available.
Stryker Mako FAQ
Is Stryker publicly traded?
Yes, on the New York Stock Exchange under the ticker SYK.
When did Stryker buy Mako?
In December 2013, for USD 1.65 billion.
What is Mako?
A robotic arm system that assists surgeons in joint replacement.
Who is the CEO of Stryker?
Kevin A. Lobo.
Where is Stryker based?
In Portage, Michigan.
Sources
Wikipedia: Stryker Corporation
